Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9.
暂无分享,去创建一个
David Bryder | Christian L. Boutwell | Todd M. Allen | Andrew M. Tager | Michael E. Talkowski | Harrison Brand | Chad A. Cowan | Kiran Musunuru | Alexei Stortchevoi | T. Allen | H. Brand | M. Talkowski | Derrick J. Rossi | K. Musunuru | A. Tager | A. Stortchevoi | P. Mandal | T. Meissner | C. Cowan | R. Collins | C. Boutwell | D. Bryder | Vladimir Vrbanac | V. Vrbanac | B. Garrison | Leonardo M. R. Ferreira | M. Friesen | Pankaj K. Mandal | Ryan Collins | Torsten B. Meissner | Max Friesen | Brian S. Garrison
[1] Mauricio O. Carneiro,et al. From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.
[2] Matthew C. Canver,et al. An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level , 2013, Science.
[3] F. Watzinger,et al. Standardization of DNA isolation from low cell numbers for chimerism analysis by PCR of short tandem repeats , 2011, Leukemia.
[4] Jiankui Zhou,et al. Dual sgRNAs facilitate CRISPR/Cas9‐mediated mouse genome targeting , 2014, The FEBS journal.
[5] I. Weissman,et al. Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle. , 2014, Cell stem cell.
[6] Jeffry D. Sander,et al. CRISPR-Cas systems for editing, regulating and targeting genomes , 2014, Nature Biotechnology.
[7] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[8] James E. DiCarlo,et al. RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.
[9] P. Glazer,et al. Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids. , 2011, Chemistry & biology.
[10] Gang Bao,et al. CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences , 2014, Nucleic acids research.
[11] Kai Li,et al. Biological and Biomedical Applications of Engineered Nucleases , 2013, Molecular Biotechnology.
[12] Ira M. Hall,et al. SAMBLASTER: fast duplicate marking and structural variant read extraction , 2014, Bioinform..
[13] E. Thiel,et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. , 2009, The New England journal of medicine.
[14] Marc Parmentier,et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.
[15] David A. Scott,et al. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells , 2014, Nature Biotechnology.
[16] Rudolf Jaenisch,et al. One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.
[17] E. Thiel,et al. Long-Term Control of HIV by CCR 5 Delta 32 / Delta 32 Stem-Cell Transplantation , 2009 .
[18] Chad A. Cowan,et al. Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. , 2013, Cell stem cell.
[19] Vanessa Taupin,et al. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo , 2010, Nature Biotechnology.
[20] Yiping Shen,et al. Next-generation sequencing strategies enable routine detection of balanced chromosome rearrangements for clinical diagnostics and genetic research. , 2011, American journal of human genetics.
[21] Cole Trapnell,et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.
[22] Lei Wang,et al. Generation of Gene-Modified Cynomolgus Monkey via Cas9/RNA-Mediated Gene Targeting in One-Cell Embryos , 2014, Cell.
[23] Matthew C. Canver,et al. Characterization of Genomic Deletion Efficiency Mediated by Clustered Regularly Interspaced Palindromic Repeats (CRISPR)/Cas9 Nuclease System in Mammalian Cells*♦ , 2014, The Journal of Biological Chemistry.
[24] Xiaoling Wang,et al. Precise Gene Modification Mediated by TALEN and Single-Stranded Oligodeoxynucleotides in Human Cells , 2014, PloS one.
[25] E. Thiel,et al. Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation. , 2011, Blood.
[26] R. Jaenisch,et al. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. 1990. , 2010, Journal of immunology.
[27] Jin-Soo Kim,et al. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases , 2014, Genome research.
[28] E. Rebar,et al. Genome editing with engineered zinc finger nucleases , 2010, Nature Reviews Genetics.
[29] William C. Olson,et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 , 1996, Nature.
[30] Kevin Kim,et al. A TALEN genome-editing system for generating human stem cell-based disease models. , 2013, Cell stem cell.
[31] Gang Bao,et al. Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection , 2014, Proceedings of the National Academy of Sciences.
[32] Feng Chen,et al. Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones. , 2014, Cell stem cell.
[33] J. Anaya,et al. Concordance of CCR5 genotypes that influence cell-mediated immunity and HIV-1 disease progression rates. , 2011, The Journal of infectious diseases.
[34] Jeffry D. Sander,et al. Efficient In Vivo Genome Editing Using RNA-Guided Nucleases , 2013, Nature Biotechnology.
[35] Global distribution of the CCR5 gene 32-basepair deletion , 1997, Nature Genetics.
[36] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[37] M. A. Saper,et al. Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.
[38] Gang Bao,et al. CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity , 2013, Nucleic acids research.
[39] Eli J. Fine,et al. DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.
[40] R. Jiao,et al. TALEN or Cas9 - rapid, efficient and specific choices for genome modifications. , 2013, Journal of genetics and genomics = Yi chuan xue bao.
[41] Kun Zhang,et al. Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs. , 2014, Cell stem cell.
[42] Peter Krawitz,et al. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish , 2013, Development.
[43] P. Duchateau,et al. Genome engineering with TAL-effector nucleases and alternative modular nuclease technologies. , 2013, Current gene therapy.
[44] Eunji Kim,et al. Targeted chromosomal deletions in human cells using zinc finger nucleases. , 2010, Genome research.
[45] Seung Woo Cho,et al. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease , 2013, Nature Biotechnology.
[46] Pei-Rong Wang,et al. HLA engineering of human pluripotent stem cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[47] Chad A. Cowan,et al. Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. , 2014, Cell stem cell.
[48] Heng Li. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.
[49] P. Duchateau,et al. Meganucleases and Other Tools for Targeted Genome Engineering: Perspectives and Challenges for Gene Therapy , 2011, Current gene therapy.
[50] J. Keith Joung,et al. TALENs: a widely applicable technology for targeted genome editing , 2012, Nature Reviews Molecular Cell Biology.
[51] J. Doudna,et al. A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.
[52] R. Jaenisch,et al. β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells , 1990, Nature.
[53] N. Krogan,et al. IFI16 DNA Sensor Is Required for Death of Lymphoid CD4 T Cells Abortively Infected with HIV , 2014, Science.
[54] Ryan M. Layer,et al. LUMPY: a probabilistic framework for structural variant discovery , 2012, Genome Biology.
[55] Jennifer Doudna,et al. RNA-programmed genome editing in human cells , 2013, eLife.
[56] C. Barbas,et al. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. , 2013, Trends in biotechnology.
[57] S. Wolfe,et al. Targeted chromosomal deletions and inversions in zebrafish , 2013, Genome research.
[58] J. Keith Joung,et al. High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells , 2013, Nature Biotechnology.
[59] Cong Peng,et al. Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing , 2011, Science.
[60] Wei-Ting Hwang,et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. , 2014, The New England journal of medicine.
[61] J. Orange,et al. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases , 2008, Nature Biotechnology.
[62] J. Keith Joung,et al. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs , 2014, Nature Biotechnology.